These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20393879)

  • 1. Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies.
    Brown C; Subramanian V; Wilcox CM; Peter S
    Dig Dis Sci; 2010 Aug; 55(8):2129-34. PubMed ID: 20393879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis.
    Goltstein LCMJ; Grooteman KV; Rocco A; Holleran G; Frago S; Salgueiro PS; Aparicio T; Scaglione G; Chetcuti Zammit S; Prados-Manzano R; Benamouzig R; Nardone G; McNamara D; Benallaoua M; Michopoulos S; Sidhu R; Kievit W; Drenth JPH; van Geenen EJM
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):922-932. PubMed ID: 34508668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting somatostatin analogues decrease blood transfusion requirements in patients with refractory gastrointestinal bleeding associated with angiodysplasia.
    Bon C; Aparicio T; Vincent M; Mavros M; Bejou B; Raynaud JJ; Zampeli E; Airinei G; Sautereau D; Benamouzig R; Michopoulos S
    Aliment Pharmacol Ther; 2012 Sep; 36(6):587-93. PubMed ID: 22831465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial.
    Goltstein LCMJ; Grooteman KV; Bernts LHP; Scheffer RCH; Laheij RJF; Gilissen LPL; Schrauwen RWM; Talstra NC; Zuur AT; Braat H; Hadithi M; Brouwer JT; Nagengast WB; Oort FA; Tenthof van Noorden J; Kievit W; van Geenen EJM; Drenth JPH
    Gastroenterology; 2024 Apr; 166(4):690-703. PubMed ID: 38158089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the treatment of refractory gastrointestinal angiodysplasia.
    Becq A; Sidhu R; Goltstein LCMJ; Dray X
    United European Gastroenterol J; 2024 Oct; 12(8):1128-1135. PubMed ID: 39229890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogues for acute bleeding oesophageal varices.
    Gøtzsche PC
    Cochrane Database Syst Rev; 2002; (1):CD000193. PubMed ID: 11869569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract.
    Orsi P; Guatti-Zuliani C; Okolicsanyi L
    Dig Liver Dis; 2001 May; 33(4):330-4. PubMed ID: 11432511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of gastrointestinal angiodysplastic lesions (GIADs): a systematic review and meta-analysis.
    Jackson CS; Gerson LB
    Am J Gastroenterol; 2014 Apr; 109(4):474-83; quiz 484. PubMed ID: 24642577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of lanreotide in patients with gastrointestinal angiodysplasia refractory to octreotide therapy].
    Ramos-Rosario HA; Badia Aranda E; Martín Lorente JL; Arias García L; Sicilia Aladrén B; Sáez-Royuela F
    Gastroenterol Hepatol; 2016 Mar; 39(3):213-4. PubMed ID: 26091778
    [No Abstract]   [Full Text] [Related]  

  • 10. Somatostatin or octreotide for acute bleeding oesophageal varices.
    Gotzsche PC
    Cochrane Database Syst Rev; 2000; (2):CD000193. PubMed ID: 10796699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Octreotide in the treatment of angiodysplasia in patients with advanced chronic renal failure].
    Rivera M; Lucero J; Guerrero A; Márquez JL; Montes R; Suñer M; Ruiz A; Valdivia MA; Mateos J
    Nefrologia; 2005; 25(3):332-5. PubMed ID: 16053016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
    Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR
    Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?
    Molina-Infante J; Perez-Gallardo B
    Dig Dis Sci; 2011 Jan; 56(1):266-7. PubMed ID: 21046246
    [No Abstract]   [Full Text] [Related]  

  • 14. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
    Nardone G; Compare D; Scarpignato C; Rocco A
    Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin therapy ameliorates chronic and refractory gastrointestinal bleeding caused by diffuse angiodysplasia in a patient on anticoagulation therapy.
    Blich M; Fruchter O; Edelstein S; Edoute Y
    Scand J Gastroenterol; 2003 Jul; 38(7):801-3. PubMed ID: 12889571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogues for acute bleeding oesophageal varices.
    Gøtzsche PC; Hróbjartsson A
    Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD000193. PubMed ID: 18677774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting somatostatin analogues provide significant beneficial effect in patients with refractory small bowel angiodysplasia: Results from a proof of concept open label mono-centre trial.
    Holleran G; Hall B; Breslin N; McNamara D
    United European Gastroenterol J; 2016 Feb; 4(1):70-6. PubMed ID: 26966525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices.
    de Franchis R
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S93-100. PubMed ID: 15077917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.
    Nardone G; Rocco A; Balzano T; Budillon G
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1429-36. PubMed ID: 10571598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation.
    Classen CF; Haffner D; Hauenstein C; Wolf R; Kyank U
    BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.